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ABSTRACT 
Background: 
Over the last decade, it is estimated that Vitamin D insufficiency has increased. 
Currently, approximately 50% of the population has Vitamin D deficiency, including all ages and 
ethnicities (Nair, 2012).  This change is thought to be partially due to behavior changes; such as 
less time spent outside, as well as an increase in the use of sunscreen while outside (Nair, 2012). 
Vitamin D insufficiency is defined as a serum vitamin D level between 21-29 ng/mL of 25-
hydroxyvitamin D [25(OH)D] (Nair,2012). Vitamin D deficiency is defined as a serum vitamin D 
level </= 20ng/mL of 25-hydroxyvitamin D [25(OH)D] (Nair, 2012). 
Purpose: 
The purpose of this research is to determine if there is adequate Vitamin D status (25-
hydroxyvitamin D [25(OH)D] >30 ng/mL) in patients with various gastrointestinal disorders; such 
as inflammatory bowel disease, liver disease, bowel resection, as well as those requiring 
parenteral nutrition following surgical resection or malabsorption issues. Low Vitamin D status 
may be a marker of increased risk for bone fractures, poor wound healing and other 
complications. A review of the literature will be conducted to summarize the evidence. This 
evidence will be used to educate providers, dietitians, diet technicians and dietetic interns on 
the importance of adequate Vitamin D status, and the connections to decline of health and 
function. The overall intent is to raise awareness of Vitamin D status and health outcomes in 
patients with GI disorders and the importance of adequate Vitamin D status. 
Methods: 
Literature was gathered by online library search using the PubMed database and Google 
Scholar. Using identified inclusion and exclusion criteria 26 studies were used and reviewed. The 
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studies were then graded using the Academy of Nutrition and Dietetics Evidence Analysis 
Worksheet. 
Results: 
Patients with gastrointestinal disorders were at a higher risk of Vitamin D deficiency and 
should be monitored for Vitamin D status. Supplementing with oral Vitamin D alone or Vitamin 
D supplied in multivitamin form is recommended to maintain adequate Vitamin D status. 
Patients with Crohn’s disease were at higher risk for Vitamin D deficiency and should be 
monitored closely. Currently, IV Vitamin D is not available in the United States. Individuals 
relying solely on parenteral nutrition, are usually only receiving 400IU of vitamin D from the 
multivitamin provided within the parenteral infusion.  UV light may be another option to be 
explored for those that cannot absorb vitamin D orally. 
Conclusion: 
1) Vitamin D status should be obtained in patients with Crohn’s disease, ulcerative 
colitis, short gut syndrome and other bowel resection surgeries, liver disease as well as those on 
parenteral nutrition with malabsorption disorders, to determine if deficiency or insufficiency is 
present. 2) Supplementation should be determined per protocol at each facility.  
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Introduction 
Vitamin D is a fat-soluble vitamin that the body is able to produce with sunlight 
exposure but is also derived from dietary intake (Palacios, et al., 2014). Vitamin D plays an 
important role in the human body to maintain bone structure, growth and mineral metabolism. 
The primary function of Vitamin D is to regulate calcium absorption and maintain homeostasis.  
Sun exposure is needed for ultraviolet-B (UVB) induced Vitamin D production to occur in the 
skin. A healthy adult after a day at the swimming pool during summer months may produce 
enough vitamin D to equal a supplementation of 10,000 to 25,000 IU (Nair,2018). Although skin 
pigmentation, application of sunscreen, and age are factors that may limit this process and vary 
per individual (Nair,2018). The intensity of UVB exposure depends on latitude, season, time of 
day and skin exposure. 
The highest source of naturally occurring dietary Vitamin D is in fatty fish such as 
salmon, tuna, mackerel, and fish liver oil.  Smaller amounts of vitamin D are found in cheese, 
beef liver, egg yolks, and some mushrooms. Fortified milk and cereals are a prime source of 
vitamin D in the United States (Shils, 2006). 
Synthesis of Vitamin D in the skin is initiated with exposure to ultraviolet-B (UVB light). 
Synthesis begins with 7-dehydrocholesterol (7-DHC) which both the outer layers of the skin, the 
epidermis and the dermis, contain.  The outer skin layers absorb UVB photons that are 
converted to cholecalciferol or vitamin D3 (Bickle, 2014). Cholecalciferol is produced in a two-
step process in which photoisomerization of UVB light and the vitamin precursor B ring forms 
pre-cholecalciferol in the upper layers of the skin.  It then undergoes heat sensitive and 
spontaneous isomerization to form the vitamin D3 molecule, cholecalciferol in the lower layers 
of the skin (Bickle, 2014). 
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Once cholecalciferol is produced, it is transported for storage in the adipose tissue or 
the liver to be metabolized via chylomicrons. Once it is in circulation it binds to the Vitamin D 
binding protein and it is released into the liver. The liver converts cholecalciferol to 25-
hydroxyvitamin D [25(OH)D] by hydroxylation of the carbon molecule on the 25 position to a 
hydroxyl group via the catalyst 25-hydroxylase, in the hepatocytes creating 25-
hydroxycholecalciferol (calcifediol or 25(OH)D) (Bikle,2007). The hepatocytes then express 
calcifediol into the plasma where it is bound to an α-globulin carrier, Vitamin D-binding protein 
(Christakos, et al., 2017). 
Calcifediol is transported to the proximal tubules of the kidneys where the expression of 
the enzyme 1-alpha-hydroxylase works with cubulin and megalin, other proteins that are 
expressed within the renal tubule and forms the active metabolite, calcitriol (1,25-
dihydroxycholecalciferol, 1,25(OH)2D) (Bikle,2007). Calcitriol then enters the circulation and is 
distributed throughout the body and organs by binding to the Vitamin D receptor (Bikle, 2007). 
It then has two major functions within the body, to increase intestinal calcium and phosphorus 
absorption and ensure osteoclasts become mature from preosteoclasts (Battault, et al, 2012). 
Calcitriol or 1,25 dihydroxyvitamin D function is to maintain calcium and phosphate 
homeostasis. Calcitriol elevates serum calcium levels to within normal range via three 
mechanisms (Shils, 2006); 1) Directly stimulating intestinal calcium absorption throughout the 
intestine and indirectly stimulating phosphate absorption (Shils, 2006); 2) Mobilization of 
calcium from the bone by activating osteoclast formation using parathyroid hormone (Shils, 
2006); and 3) Calcitriol and parathyroid hormone stimulate reabsorption of calcium within the 
distal tubule in the kidney (Shils, 2006). 
When there is a low serum calcium level, parathyroid hormone (PTH) regulates an 
increase in 1-alpha hydroxylase by increasing CYP27B1 gene expression inside the kidney (Shils, 
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2006). When Vitamin D deficiency is present, there is an increase in 1-alpha hydroxylase (Shils, 
2006). When deficiency of Vitamin D is not present, the presence of 1-alpha hydroxylase is 
suppressed causing a negative feedback effect (Shils, 2006).  
Increased parathyroid hormone which can be caused by a rise in serum calcium 
concentration and a fall in phosphorus will stimulate 1,25 dihydroxyvitamin D production and 
inhibit parathyroid hormone secretion (Shils, 2006). Vitamin D receptors on the cell surface may 
be down regulated playing a role in Vitamin D activation (Shils, 2006).   
Vitamin D Receptors (VDR) are nuclear receptor which the metabolite of vitamin D, 
calcitriol, activating the VDR (Moore, et al., 2006). After activation VDR dimerizes with the 
retinoid X receptor creating a complex that acts as a transcription factor for gene expression for 
transport proteins. These transport proteins are involved in calcium absorption in the intestine 
(Moore, et al., 2006) and a variety of other metabolic pathways including inhibiting growth of 
cancer cells and immune response (Adorini, et al., 2006). VDRs can be expressed by cells in the 
brain, heart, skin, as well as breast and gonads (Dusso, 2011). Activation of VDR in the bone, 
intestine, kidney and parathyroid gland cells regulate calcium and phosphorus in the blood and 
bone maintenance along with parathyroid hormone and calcitonin (Dusso, 2011). VDR also 
regulates cell differation and proliferation (Puccetti, et al, 2002).  
Vitamin D is absorbed in the intestine, via the jejunum and ileum by way of the portal 
and lymphatic system (Bickle, 2007). When vitamin D is ingested through diet in the form of 
fatty fish, fish liver oil, egg yolks or fortified foods, it is emulsified into lipids within the stomach 
and duodenum (Reboul, 2015).  The fat-soluble compound enters the lipoprotein fraction and 
then can be absorbed into the lymphatic system. It is then absorbed in the proximal small 
bowel, appears to be more rapid in the duodenum and quickly converted to 25-OHD in the liver 
(Mueller, 2012).   Bile salts are required for Vitamin D absorption for solubilization in the micelle 
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(Shils, 2006). When the production of bile salts is impaired, absorption of Vitamin D can be 
impaired as well (Shils, 2006). Once solubilization has occurred it is then delivered to the 
enterocyte apical membrane and passively diffused within the enterocytes which then form into 
chylomicrons for absorption into the lymphatic system and then to the bloodstream (Shils, 
2006). 
Without proper Vitamin D status, demineralization of bone can occur in adults, leading 
to a condition called osteomalacia. Without adequate Vitamin D status, a decrease in the body’s 
ability to absorb calcium and phosphorus from diet occurs.  A decrease in calcium and 
phosphorus within the body then increases parathyroid hormone which increases osteoclast 
activity leading to bone weakness and decreased bone density (Nair, 2018). Osteomalacia can 
soften bones causing bones to become weakened and may bend or break, increasing risk of falls 
and fracture which can increase the number of hospitalizations (Nair, 2018; Meehan, et al., 
2014; Jiang, 2018).   
It is thought Vitamin D status can play a role in many chronic diseases and increasing 
research is emerging (Meehan, et al., 2014) suggesting an association among vitamin D 
deficiency and osteoporosis, cognitive function, cardiovascular disease, diabetes, hypertension, 
cancer, mortality, depression, and increasing healthcare costs (Autier,2019; Nair,2018; Jiang, 
2018). Studies are suggesting negative outcomes with lower Vitamin D status and chronic 
disease and an increased risk for mortality and increased healthcare costs (Mckinney, 2011). 
Currently, the deficiency of Vitamin D in the human population is a pandemic that is not 
well recognized (Mckinney, 2011). It is estimated that 50% of the world’s population is affected 
by Vitamin D insufficiency (Nair, 2018) and nearly 1 billion people worldwide have deficient or 
insufficient Vitamin D status (Pfotonhauer, et al., 2017). Vitamin D insufficiency was also found 
in countries with low latitudes which generally are exposed to adequate sunlight as well as 
 8 
 
industrialized countries which generally fortify foods to provide a higher intake of dietary 
Vitamin D (Palacios, et al., 2014). Vitamin D insufficiency affects males and females, all 
ethnicities, all age groups and estimated to affect one billion people (Palacios, et al.,2014). It is 
hypothesized that due to less outdoor exposure to sunlight and the use of sunscreen likely 
contribute to the rise in Vitamin D deficiency (Nair, 2012).  As a person ages, their risk of Vitamin 
D deficiency increases, older adults (age >65) with Vitamin D deficiency was found to range from 
20-100% in the United States alone (Meehan, et al.,2014). This may be related to less time spent 
outside or a decline in intakes of Vitamin D sources of food. Other factors that may play a role in 
Vitamin D status may include increased adipose tissue or decreased synthesis of Vitamin D in 
the body (Meehan, et al.,2014). 
There are certain population groups who are at higher risk of Vitamin D deficiencies as 
including those who are homebound or spend little time outdoors, use sunscreen daily, live in 
higher latitudes, have darker skin tone, are overweight/obese, who are 60 years and older, have 
intestinal malabsorption disorders, and infants that are exclusively breast fed. 
The metabolite 25-hydroxyvitamin D [25(OH)D] is usually used as a lab marker to 
determine the Vitamin D status due to its reflection of Vitamin D from all sources (sunlight and 
diet) and has a half-life of 2-3 weeks. The active form of Vitamin D (1,25(OH)2D has a half-life of 
4 hours. Vitamin D Status is determined by the laboratory value Serum 25-hydroxyvitamin D 
(25(OH)D). See Table 2 for recommendation of serum Vitamin D levels and Table 1 for 
recommended intakes based on age. 
Vitamin D requirements depend upon a person’s age. Requirements are the same for 
males and females.   
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Table 1 Vitamin D recommendations ("Office of Dietary Supplements - Vitamin D"). 
Age Recommendation 
0-12 months 400 IU 
1-13 years 600 IU 
14-18 years 600 IU 
19-50 years 600 IU 
51-70 years 600 IU 
>70 years 800 IU 
Pregnancy or Lactation 600 IU 
 
Table 2 Recommended serum 25-Hydroxyvitamin D levels ("Office of Dietary Supplements - 
Vitamin D"). 
nmol/L ng/mL Health Related 
< 30 < 12 Vitamin D deficiency 
Osteomalacia in adults 
30 to < 50 12 to < 20 Inadequate for bone health 
and general health in healthy 
individuals 
>50 >20 Adequate for bone health 
and general health of healthy 
individuals 
>125 >50 May have adverse effects 
with high levels 
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While it is known that Vitamin D has an important role in skeletal health, Vitamin D 
absorption can be affected by disorders of the intestine, liver disease or bowel surgical 
interventions which can result in malabsorption of Vitamin D, as well as calcium and phosphorus 
and lead to osteoporosis (Bickle, 2007). Gastrointestinal diseases that contribute to known 
malabsorption of Vitamin D include bowel disorders and surgeries such as post-gastrectomy, 
celiac disease, inflammatory bowel disease, pancreatic insufficiency, short gut syndrome, and 
bariatric surgery. Inflammatory bowel disease and Vitamin d deficiency may be linked by 
immunological effects (Neilson, 2019).  As Inflammatory bowel disease consists of inflammation 
and ulceration of the gastro-intestinal tract and Vitamin D has been recognized for an important 
role in gut mucosal immunity regulation (Fletcher et al., 2019). Studies suggest Vitamin D has a 
role protecting gut epithelial integrity, T cell development and function, promoting anti-
inflammatory cytokines and innate immune barrier function (Fletcher et al., 2019). Vitamin D is 
thought to have a direct effect on the immune system due to its role in T cell development and 
function (Mudambi, 2018). Vitamin D receptors play a role of being able to mitigate 
intracellularly and activating cytokines and while being found to express within cells that 
comprise the immune system, such as T cells and macrophages (Mudambi, 2018). Vitamin D 
promotes synthesis of Interleukin 10 (IL-10) which is an anti-inflammatory cytokine and plays a 
role in the development of Inflammatory bowel disease (Mudambi, 2018).  IL-10 also plays an 
important role as an anti-inflammatory cytokine that is secreted by macrophages, monocytes 
and epithelial cells which then can release the pro-inflammatory cytokine TNT-a (Mudambi, 
2018).  TNT-a causes IL-10 to inhibit CD 4 T cells expression and cause an inflammatory response 
in Inflammatory bowel disease (Mudambi, 2018).   
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Furthermore, hepatic disease may also contribute to Vitamin D deficiency due to 
cirrhosis, hepatitis (chronic, alcoholic and viral) and those that are status post liver transplant 
(Bickle, 2007). Bowel diseases that affect the small bowel distally as well as the large intestine 
can alter absorption of Vitamin D (Shils,2006). This is an area that is beginning recently to be 
investigated and may need more research and awareness in the future.  
 
 
Statement of Purpose 
The purpose of this review of the literature is to determine adequate Vitamin D status 
(25-hydroxyvitamin D [25(OH)D] >30) in gastrointestinal disorders such as inflammatory bowel 
disease, intestinal failure, patients on parenteral nutrition and bowel resections due to possible 
reduced ability to absorb vitamin D. The review of literature will summarize the research in this 
area to better inform providers, dietitians, dietetic technicians and dietetic interns on the 
importance of monitoring Vitamin D status in patients with gastrointestinal and liver disorders, 
with the goal of preventing secondary health consequences. The overall intent is to raise 
awareness of Vitamin D status and health outcomes and the importance of adequate Vitamin D 
status in hospital clinicians. 
 
Objectives 
1. To review the literature relative to Vitamin D status in patients with gastrointestinal 
disorders and if they are at risk for Vitamin D deficiency.  
2. To develop educational materials to assist healthcare providers in understanding the 
role of Vitamin D status in health outcomes. 
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Specific Aims 
1. To conduct a literature review to determine the usefulness of routinely checking for 
adequate Vitamin D status in patients with a history of gastrointestinal disorders both 
disease related and surgical. It is assumed that Vitamin D levels are not generally 
checked in an acute setting unless there is a history of deficiency.  
2. To evaluate the correlation between Vitamin D status and malabsorption in 
gastrointestinal disorders. 
3. To establish evidence to be used to educate healthcare providers. 
4. To determine if there is a relationship between negative outcomes of skeletal health in 
patients and gastrointestinal disorders. 
5. To determine if adequate Vitamin D status improve outcomes in patients with 
gastrointestinal disorders? 
 
Approach to meeting specific aims 
The guidelines developed by the Academy of Nutrition and Dietetics will be used to perform the 
“Evidence Based Analysis” process for this project. 
 
Step 1: Develop a Question 
 This question was developed as a focus for my creative component. I am a clinical 
inpatient dietitian with an interest in acute care, where many patients suffer from 
gastrointestinal disorders. I would like to learn more about the role of Vitamin D and bowel 
disease and bowel surgeries that can affect hospitalized patients. 
 
Step 2: Gather and Classify Research 
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Methods- Literature Search 
Research articles were gathered from online databases, PubMed and Google Scholar. Reviewed 
60 abstracts and introductions to determine if met inclusion criteria. Many were duplicates or 
did not meet criteria, unfortunately, many studies in this area involved pediatrics or rodents, 26 
full text articles were reviewed (Table 3). Position papers from the academy were also reviewed. 
Reviewed articles using AND evidence analysis manual (Appendix 1). 
 The following keywords were used to find articles pertinent: vitamin d and 
gastrointestinal disease, vitamin d status, vitamin d and drug interactions, vitamin d and liver 
disease, vitamin d status in intestinal surgeries, vitamin d and long-term parental nutrition, 
vitamin d and intestine failure, vitamin d and surgical patients 
Table 3 - Criteria used for Literature Search 
Inclusion Criteria Exclusion Criteria 
Adult aged 18 years old and older Youth under < 18 years 
Serum vitamin D <30ng/mL Subjects with only adequate Vitamin D levels 
Gastrointestinal disease (chronic, surgical and 
liver disease) 
Studies published over 10 years ago 
Studies published in the last 10 years Studies not in the English language 
English language 
 
Studies that do not involve human subjects 
Human subjects  
 
A presentation with findings will be given to an interdisciplinary team to create 
awareness of monitoring Vitamin D levels in patients with gastrointestinal disorders. Feedback 
will be requested in the form of a survey. IRB approval was not indicated as this is considered a 
quality improvement effort.
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Table 4 Summary of Articles Reviewed 
Grading of articles see appendix 1 
  
Citation& Grade Study Purpose Study 
Population 
Methods Outcomes Conclusions Limitations 
Parenteral Nutrition 
Thomson, Patti, and Donald 
R. Duerksen. "Vitamin D 
Deficiency in Patients 
Receiving Home Parenteral 
Nutrition". Journal of 
Parenteral and Enteral 
Nutrition, vol 35, no. 4, 2011, 
pp. 499-504. Wiley, 
doi:10.1177/0148607110381
269. 
 
Grade I 
Measure 25(OH)D 
levels in patients 
enrolled in a 
provincial HPN 
program to 
determine 
adequacy of 
vitamin D 
supplementation. 
 
 
Adult patients 
on home TPN 
for >1 month in 
the Monitoba 
Home Nutrition 
Program.  
 
 
22 patients 
qualified for 
this study. June 
2008 to July 
2009 
25(OH)D was 
measured 
along with 
phosphorus, 
mg and ionized 
calcium. Diet 
recall was 
looked at to 
determine 
dietary vitamin 
D intake by 
diet analysis by 
anRD. 24hour 
diet recall. All 
patients 
received IV 
MVI that 
contains 200 IU 
vit D3. 
Vit D def 
<50nmol/L 
(20ng/mL) and 
insufficiency 
>50nmol/L but 
<75 nmol/L (30 
ng/mL).  
Reasons for TPN 
gastrointestinal 
dysmotility 
(45%) 
malabsorption/s
hort bowel 
syndrome 
(36%). GI 
obstruction 
(18%). 
 
Deficiency was 
present in 15 
patients and 
insufficiency 
was present in 6 
patients. 
1 patient was 
not deficient 
and was taking 
2000IU d3 in 
addition to IV 
MVI. 
 
There was no 
correlation 
In this study a 
high prevalence 
of vitamin D 
insufficiency/ 
deficiency was 
found in 
patients 
receiving home 
TPN. All patients 
that were not 
receiving 
additional 
supplements 
had serum 
levels in the 
subnormal 
range. 
 
Exposure to 
sunlight may be 
limited in HPN 
due to 
underlying 
conditions 
limiting time 
spent outside. 
The clinical 
impact of 
deficiency 
and optimal 
supplemental 
dose of 
replacement 
require 
further study. 
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found in 
intestinal length 
with those with 
short bowel 
syndrome. 
All patients had 
normal ca, phos 
levels at time of 
vit d assessment   
 
Also at risk due 
to GI disorders 
that limited 
intestinal 
absorption.  
 
Vit D should be 
routinely 
supplemented 
and 25(OH)D 
levels 
monitored. 
Bharadwaj, Shishira et al. 
"Prevalence and Predictors of 
Vitamin D Deficiency And 
Response To Oral 
Supplementation In Patients 
Receiving Long-Term Home 
Parenteral Nutrition". 
Nutrition in Clinical Practice, 
vol 29, no. 5, 2014, pp. 681-
685. Wiley, 
doi:10.1177/0884533614539
178. 
 
Grade I 
Determine the 
prevalence and 
predictors of 
vitamin D 
deficiency in long 
term home TPN 
patients 
79 patients met 
eligibility 
criteria.  
Eligible patients 
were classified 
by mean serum 
vitamin D. 
Sufficient:>30n
g/mL 
Insufficient:20-
30ng/mL 
Deficient:<20ng
/mL 
 
Inclusion- adult 
patients on 
HPN >6 
months.  
Excluded if 
serum vit D 
level was not 
recorded. 
Age, sex, BMI, 
HPN indication, 
comorbidities 
that affect vit 
D, medications 
was taken 
from medical 
records. 
 
All received IV 
MVI containing 
200UI of vit D. 
Oral 
supplementati
on of 50000 IU 
was prescribed 
for patients 
identified to 
have a vit D 
level 
<20ng/mL. 
20 Sufficient 
24 Insufficient 
35 Deficient 
35 were 
prescribed 
50000IU weekly 
44 were 
prescribed 
50000IU twice 
weekly 
24 were 
prescribed 
50000IU thrice 
weekly 
 
Absence of 
jejunum was 
associated with 
5 fold increased 
in likelihood of 
deficiency. 
Only a small 
amount of HPN 
patients had 
sufficient levels. 
HPN patients 
should be 
routinely 
screened for Vit 
D status. 
Retrospective 
study, unable 
to assess how 
patients were 
taking oral 
supplements. 
HPN 
macronutrien
t content was 
not included 
in this study. 
It was 
assumed that 
macronutrien
ts such as 
lipids would 
not affect 
metabolism 
of oral 
vitamin D 
supplementat
ion. Only 79 
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Routine 
assessment of 
serum vit d has 
become 
standard of 
practice. 
of 467 
patients on 
HPN were 
included due 
to vit d level. 
Pittas, Anastassios G. et al. 
"Role of Vitamin D In Adults 
Requiring Nutrition Support". 
Journal of Parenteral And 
Enteral Nutrition, vol 34, no. 
1, 2009, pp. 70-78. Wiley, 
doi:10.1177/0148607109349
061. Grade I 
Reviews methods 
for assessing 
vitamin D status 
and strategies to 
restore vitamin D 
status in patients 
on EN or PN who 
are at high risk for 
low vitamin D 
levels.  
 
     
Fan, S., Ni, X., Wang, J., 
Zhang, Y., Tao, S., Kong, W., 
Li, Y. and Li, J. (2016). High 
Prevalence of Suboptimal 
Vitamin D Status and Bone 
Loss in Adult Short Bowel 
Syndrome Even After 
Weaning Off Parenteral 
Nutrition. Nutrition in Clinical 
Practice, 32(2), pp.258-265. 
Grade I 
Limited data on 
short bowel 
without 
parenteral 
dependence. 
Investigate 
incidence of 
suboptimal 
vitamin d status 
and bone loss in 
adult short bowel 
syndrome after 
weaning off 
parenteral 
nutrition. 
Prospective 
study of 60 
adult patients 
with SBS. 
Serum vit D 
was measured. 
BMD was 
measured. 
Medical 
records and 
various labs 
were collected 
Suboptimal 
vitamin D levels 
were found in 
all individuals 
studied. Low 
vitamin d levels 
are associated 
with BMD. Even 
with vitamin D 
replacement is 
was difficult to 
achieve 
satisfactory 
status. 
Importance in 
surveillance of 
vit D levels and 
BMD and 
considerations 
of alternative 
methods 
following 
weaning 
parenteral 
nutrition. 
1)single 
center study 
2)only 60 
patients with 
SBS 
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Napartivaumnuay, Navaporn, 
and Leah Gramlich. "The 
Prevalence of Vitamin D 
Insufficiency and Deficiency 
and Their Relationship With 
Bone Mineral Density And 
Fracture Risk In Adults 
Receiving Long-Term Home 
Parenteral Nutrition". 
Nutrients, vol 9, no. 5, 2017, 
p. 481. MDPI AG, 
doi:10.3390/nu9050481. 
Grade I 
Retrospective, 
observational 
Determine 
prevalence of 
vitamin D 
insufficiency/defic
iency and bone 
mineral density 
and 10-year fx risk 
in adults on long 
term HPN. 
Northern 
Alberta, Canada 
on HPN. 
All patients 
received IV MVI 
routinely 
containing 
200IU of 
vitamin D3.  
Adult patients 
on HPN >6 
months. 
Those with 
malignancy or 
that did not 
have a vit D 
level or BMD 
were excluded. 
Eligible 
patients 
grouped 
according to vit 
D levels, 
sufficient, 
insufficient, 
deficient. 
Presence of 
bone mineral 
disease and 
degree. 
62 of 186 
patients were 
included. 
Mean age 53.8 
Most common 
cause for HPN 
was short bowel 
syndrome. 
Mean vit d level 
was 25.6ng/mL. 
15 were 
sufficient 
31 insufficient 
16 deficient. 
64.5% have 
abnormal BMD. 
50% had mod-
high fx risk. 
There was found 
to be 
suboptimal 
levels of vitamin 
D commonly in 
home HPN long 
term patients. 
Small study 
Retrospective 
       
       
        
Intestinal Failure 
Grenade, N., Kosar, C., 
Steinberg, K., Avitzur, Y., 
Wales, P. and Courtney-
Martin, G. (2016). Use of a 
Loading Dose of Vitamin D for 
Treatment of Vitamin D 
Deficiency in Patients with 
Intestinal Failure. Journal of 
Parenteral and Enteral 
Nutrition, 41(3), pp.512-516. 
Grade I 
 
To determine a 
loading dose in 
vitamin d deficient 
patients with 
intestine failure 
Review of 
patient cases in 
which loading 
dose was 
trailed in 
pediatric 
patients that 
had intestinal 
failure 
Review of 
patient cases 
in which 
loading dose 
was trailed in 
pediatric 
patients that 
had intestinal 
failure 
Treatment with 
a dose of 
vitamin D one 
time per week, 
has been shown 
to restore 
serum levels of 
25-OH-D to 
normal levels in 
children with 
short bowel 
syndrome.  
D3 
cholecalciferol 
exhibits an 
effect treatment 
for children with 
intestinal 
failure. 20000-
40000 IU of 
vitamin D once 
per week and a 
daily dose of 
4000-6000 IU/d 
Limited 
studies using 
loading dose. 
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on the 
remaining 6 
days. 
Ellegård, L., Kurlberg, G. and 
Bosaeus, I. (2013). High 
prevalence of vitamin D 
deficiency and osteoporosis 
in out-patients with intestinal 
failure. Clinical Nutrition, 
32(6), pp.983-987. 
Grade I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To determine 
prevalence of 
vitamin D 
deficiency and 
osteoporosis in 
those with 
intestinal failure. 
106 patients 
who were seen 
1 or more times 
by an 
outpatient 
surgical clinic 
for intestinal 
failure with the 
department of 
surgery in 
sahlgrenska 
university 
hospital were 
reviewed in 
Gothenburg, 
Sweden 
Serum vitamin 
D levels were 
taken. 
Severe < 25 
nmol/l 
Deficiency 
<50nmol/l 
Marginal 
vitamin D <75 
Optimal 75-
150 
Retinol was 
looked at in 48 
patients, a-
tocpherol in 47 
patients, 
vitamin A and 
E were defined 
as <1 and 
<14nmol 
Bone density 
was assessed 
by DXA in78 
patients 
Osteoporosis 
was defined as 
spinal or bone 
density score T 
score below -
2.5 SD and 
osteopenia 
45 patients 
were only 
taking a 
multivitamin 
which included 
5 ug of vitamin 
D. 29 were on 
PN 
supplementatio
n, 29 were on ca 
and vit D 
supplementatio
n, 3 were on 
indv doses of 
vitamin d. The 
45 on an MVI 
had lower vit d 
levels compared 
to the 61 on 
supplementatio
n.  
67% of patients 
had a serum 
level <50, 25% 
were severely 
deficient, 12% 
had optimal 
levels. No 
significant 
differences with 
or without PN. 
No correlation 
was found 
between 
vitamin D levels 
and bone 
density in 
lumbar or 
femoral regions. 
Latitude was 
not assessed 
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was defined as 
a t score 
between -1 
and-2.5. 
Height and 
weight were 
also measured. 
12% that had a 
DXA scan were 
normal, 44% 
were 
osteopenia and 
44% 
osteoporotic. 
Margulies, S., Kurian, D., 
Elliott, M. and Han, Z. (2015). 
Vitamin D deficiency in 
patients with intestinal 
malabsorption syndromes - 
think in and outside the gut. 
Journal of Digestive Diseases, 
16(11), pp.617-633. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Review Review Review Review •High instance 
of vitamin D 
deficiencies in 
patients with 
intestinal 
malabsorption 
•No strong 
relationship 
between 
intestinal 
vitamin d 
absorption and 
deficiency 
•Insufficient 
sunlight 
exposure is a 
significant factor 
for vitamin d 
deficiency in 
patients with 
intestinal 
malabsorption 
syndromes. 
•Inflammation 
and 
hyperparathyroi
dism are 
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important in vit 
d deficiencies as 
a cause when an 
intestinal 
malabsorption 
syndrome is 
present. 
•IBD including 
crohns and UC 
can be caused 
by genetic and 
environmental 
factors. Vit d def 
in presence of 
IBD. 
•Reduced 
vitamin d 
absorption 
ability in 
patients with 
intestinal 
malabsorption 
•Vitamin d 
supplementatio
n for cyctic 
fibrosis 
•Celiac disease 
and vitamin d 
supplementatio
n 
•Vit d 
supplementatio
n for patients 
with IBD 
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Inflammatory Bowel Disease 
Sharifi, A., Nedjat, S., Vahedi, 
H., Veghari, G. and 
Hosseinzadeh-Attar, M. 
(2018). Vitamin D Status and 
Its Relation to Inflammatory 
Markers in Patients with Mild 
to Moderate Ulcerative 
Colitis. Middle East Journal of 
Digestive Diseases, 10(2), 
pp.84-89. 
Grade I 
 
 
 
 
to assess the 
vitamin D status 
and its 
associations with 
erythrocyte 
sedimentation 
rate (ESR) and 
high sensitivity c-
reactive protein as 
inflammatory 
markers in UC 
patients. 
analytical cross-
sectional study, 
90 patients 
with mild-mod 
UC were 
assessed. 
25OHD, 
parathyroid 
hormone, ESR 
and hs-CRP 
were 
measured. 3-
day dietary 
recall, stats by 
STATA. 
mean 25OHD 
was 33.1. 38.9% 
of patients were 
vit d def or 
insufficient. No 
sig correlation 
between 
25OHD, hs-crp, 
BMI and disease 
duration. No 
differences in 
serum vit D 
between men 
and women. 
Mean daily 
intakes from 
diet and calcium 
were 189.5IU 
and 569.5mg 
mean 25OHD 
was 33.1. 38.9% 
of patients were 
vit D def or 
insufficient. No 
sig correlation 
between 
25OHD, hs-crp, 
BMI and disease 
duration. No 
differences in 
serum vit D 
between men 
and women. 
Mean daily 
intakes from 
diet and calcium 
were 189.5IU 
and 569.5mg 
No control 
group. 39 
patients 
declined to 
participate. 
Only patients 
with mild- 
mod UC were 
assessed. 
Vernia, P., Burrelli Scotti, G., 
Dei Giudici, A., Chiappini, A., 
Cannizzaro, S., Afferri, M. and 
de Carolis, A. (2018). 
Inadequate sunlight exposure 
in patients with inflammatory 
bowel disease. Journal of 
Digestive Diseases, 19(1), 
pp.8-14. 
Grade I 
 
Evaluate sunlight 
exposure in 
patients with IBD- 
inflammatory 
bowel disease in 
Italy. 
Case controlled 
study, 292 
patients with 
IBD. 132 had 
Crohn’s, 160 
with UC. 80 
diseased 
patients and 
540 healthy 
controls. 
Validated 
questionnaire 
to evaluate 
sunlight 
exposure. Data 
was then 
compared with 
age and 
gender. 
78 or 292 
patients with 
IBD had low sun 
exposure. 169 
had moderate 
sun exposure. 
45 had high 
exposure. 132 
with Crohn’s 
disease were 
more likely to 
have abnormal 
sun exposure 
than those with 
Patients with 
inflammatory 
disease had 
significantly less 
sunlight 
exposure than 
controls in Italy. 
Patients with 
IBD may benefit 
from increase 
sunlight 
exposure, it 
areas that are 
more at risk for 
One location 
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UC. The control 
group had more 
sun exposure. 
less sun. Vit D 
levels when not 
taking oral 
supplements did 
not seem to 
correlate 
significantly 
with sun 
exposure in IBD. 
Lund-Nielsen, J., Vedel-Krogh, 
S., Kobylecki, C., Brynskov, J., 
Afzal, S. and Nordestgaard, B. 
(2018). Vitamin D and 
Inflammatory Bowel Disease: 
Mendelian Randomization 
Analyses in the Copenhagen 
Studies and UK Biobank. The 
Journal of Clinical 
Endocrinology & Metabolism, 
103(9), pp.3267-3277. 
Grade I 
Serum levels of 
25(OH)D may be 
associated with 
risk of Crohn’s 
disease and 
ulcerative colitis. 
 Mendelian 
randomization 
study, 120,013 
subjects from 
Copenhagen 
City Heart 
Study, 
Copenhagen 
General 
Population 
Study, 
Copenhagen 
patients with 
IBD.  
35,558 has 
serum vitamin 
D levels and 
115,110 were 
genotyped. 
653 cases were 
identified for 
Crohn’s (58 vit 
d available) 
and 1265 cases 
for ulcerative 
colitis (113 vit 
D available). 
Hazard ratios 
for higher 
plasma vitamin 
d levels were 
examined. 
Hazard ratios 
for 10 nmol/L 
higher 25OHD 
were 1.04  for 
Crohn’s and 
1.13 for UC. 
Combined allele 
score for 
25OHD was 
associated with 
an increase in 
plasma 25OHD 
by 1.4 nmol/L 
A major role of 
vitamin D levels 
and IBD was not 
shown. 
Genetic 
pleiotropy 
and linkage 
diequilibrium 
Zammit, S. (2018). Vitamin D 
deficiency in a European 
inflammatory bowel disease 
inception cohort: an Epi- IBD 
study. European Journal of 
Gastroenterology & 
Hepatology, 2018, pp.1-7. 
Determine 
relationship of 
demographics, 
severity, 
phenotype and 
QOL, treatments 
received in 
238 patients 
were included 
with IBD from 
2010-2011. 
Patients had 
vitamin D levels 
available and 
IBD was 
measured 
using the 
Harvey 
Bradshaw 
Index for CD 
Of 238 patients 
a total of 188 
patients were 
from western 
European 
countries. The 
remainder were 
Vitamin D levels 
at dx can 
indicate 
presence of 
more severe 
IBD. Smoking 
was associated 
Factors that 
influence 
vitamin D in 
IBD 
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Grade I patients with IBD 
with low serum 
vitamin D levels 
had serum 
vitamin D 
measured at 
follow up 
appointments. 
All were part of 
Epi- IBD cohort. 
and SCCAI for 
UC. 
QOL was 
measured 
using IBD short 
questionnaire. 
Demographics, 
and treatments 
were recorded. 
Vitamin D was 
measured and 
deficient was 
classified<50n
mol/l 
Insufficient 50-
75nmol/l 
Normal </= 
75nmol/l 
Other factors 
such as sex, 
phenotypes, 
disease 
activity, 
medications 
used, smoking 
and surgery 
were also 
looked at. 
from eastern 
European 
countries. 16 of 
the patients 
underwent 
surgery over a 5 
year period. 
Female patients 
had higher 
vitamin d levels 
overall at dx. 
79% of 
participants 
were 
insufficient or 
deficient at 
diagnosis and 
no difference in 
type of IBD. A 
positive 
correlation was 
found between 
serum vitamin d 
levels and time 
since initial dx 
of IBD and being 
on appropriate 
medications. 
Only 2 patients 
were on vitamin 
d 
supplementatio
n the first year 
of dx.  
with lower 
serum vitamin d 
levels. Vitamin D 
and QOL had a 
known 
association. 
Serum vitamin d 
and wellbeing 
were 
associated. 
 
 24 
 
Han, Y., Yoon, H., Lim, S., 
Sung, M., Shin, C., Park, Y., 
Kim, N., Lee, D. and Kim, J. 
(2017). Risk Factors for 
Vitamin D, Zinc, and Selenium 
Deficiencies in Korean 
Patients with Inflammatory 
Bowel Disease. Gut and Liver, 
11(3), pp.363-369. 
Grade I 
Micronutrient 
deficiency as well 
as risk factors for 
deficiency in IBD 
patients in Korea. 
83 IBD patients 
in Korea were 
recruited from 
2013 to 2015 at 
Seoul National 
University 
Bundang 
Hospital who 
had blood 
levels for 
vitamin d, zinc 
and selenium. 
Serum 25OHD, 
zinc and 
selenium were 
examined. 
Vitamin D was 
also looked at 
in IBD vs 
healthy 
patients, in age 
and sex-
controlled 
groups. 
74/83 had 
suboptimal 
vitamin D levels. 
Those with IBD 
had significantly 
reduced levels 
compared to 
healthy 
subjects. 39% 
had lower 
serum zinc and 
30.9% had 
lower selenium 
levels. Female 
and Crohn’s 
disease were 
more likely to 
have vitamin d 
deficiency. 
Those <40 years 
of age were 
more likely to 
have a zinc 
deficiency. 
Female and 
lower serum 
albumin were 
risk factors in 
selenium 
deficiency. 
Monitoring of 
micronutrients 
in Koreans with 
IBD is 
suggested. 
Disease 
activity was 
not measured 
due to 
retrospective 
study. 
Dietary intake 
was also not 
monitored. 
Frigstad, S., Høivik, M., 
Jahnsen, J., Dahl, S., 
Cvancarova, M., Grimstad, T., 
Berset, I., Huppertz-Hauss, G., 
Determine the 
prevalence of 
vitamin D 
deficiency and 
IBD patients 
were recruited 
from 9 local 
hospitals in 
Data from 
clinical and 
epidemiologica
l were 
200/408 49% of 
subjects had a 
serum vitamin d 
level < 
In CD and UC 
vitamin d def 
was common 
(higher in CD) 
Did not test 
sunlight 
exposure. 
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Hovde, Ø., Torp, R., Bernklev, 
T., Moum, B. and Jelsness-
Jørgensen, L. (2016). Vitamin 
D deficiency in inflammatory 
bowel disease: prevalence 
and predictors in a Norwegian 
outpatient population. 
Scandinavian Journal of 
Gastroenterology, 52(1), 
pp.100-106. 
 
Grade I 
variables 
associated with 
this deficiency in 
IBD outpatients.  
Norway. And 
enrolled in an 
observational, 
multi center 
study from 
March 2013 to 
April 2014. 
collected from 
medical 
records and 
interviewing of 
subjects. 
Serum vit D 
was performed 
in a laboratory.  
50nmol/L. 53% 
with CD, 44% 
with UC. 
In CD disease 
activity 
measured as 
the HBI was 
inversely 
associated with 
vit d def. No 
association was 
seen in UC using 
the SCCAI 
scores. In CD 
there was an 
association with 
vit D def and 
relapses in the 
previous year. 
and associated 
with disease 
activity, relapses 
and higher 
inflammatory 
activity.  
Caviezel, D., Maissen, S., 
Niess, J., Kiss, C. and Hruz, P. 
(2017). High Prevalence of 
Vitamin D Deficiency among 
Patients with Inflammatory 
Bowel Disease. Inflammatory 
Intestinal Diseases, 2(4), 
pp.200-210. 
 
Grade I 
Vitamin D levels 
were compared 
between IBD 
patients and IBS 
patients. 
Cross sectional 
study 
181 patients, 
156 with IBD 
and 25 with IBS 
Disease 
activity, 
inflammatory 
markers, 
physical 
activity and 
season were 
collected. 
58 CD patients 
and 25 UC 
patients had a 
vitamin D level 
< 50nmol/L. CD 
had significantly 
lower levels 
than IBS 
patients. This 
was not found 
in UC patients. 
Seasonal 
variation was 
also seen in CD 
patients. Lower 
Vitamin D 
deficiency was 
common in all 
IBD, but higher 
in CD patients. 
Small number 
of IBS 
patients 
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values in the 
spring than 
summer. 
Tan, B., Li, P., Lv, H., Yang, H., 
Li, Y., Li, J., Wang, O. and 
Qian, J. (2018). Treatment of 
vitamin D deficiency in 
Chinese inflammatory bowel 
disease patients: A 
prospective, randomized, 
open-label, pilot study. 
Journal of Digestive Diseases, 
19(4), pp.215-224. 
 
Grade I 
Evaluate vitamin D 
supplements in 
Chinese 
inflammatory 
bowel disease UC 
and CD that were 
experiencing 
insufficiency or 
deficiency. 
Prospective, 
parallel-
controlled, 
open-label, 
pilot 
randomized 
clinical study. 
UC and CD 
patients in IBD 
clinic of Peking 
Union Medical 
College 
Hospital 
between Dec 
2010 and Feb 
2014. 
Inclusion 
criteria 
Adult >18years 
with UC/CD 
Vitamin D 
insufficiency or 
deficiency by 
12-month f/u. 
Patients were 
randomly 
assigned into 3 
groups. One 
group received 
vit d3, 
150000IU one 
per 3 months 
and 200mg 
elemental 
calcium. 
2nd group 
200mg 
elemental 
calcium 3x per 
day. 3rd group 
control group. 
Improvement 
in 25OHD was 
assessed as 
well as bone 
density and 
disease 
activity. 
65 UC and 59 
CD patients 
completed the 
study. The pre 
and post 
treatment of 
group 1 had 
higher levels of 
25oHD than 2 or 
3. No difference 
in bone density 
or disease 
activity. 
Vitamin D 
supplementatio
n is required to 
treat 
insufficiency 
and deficiency 
in UC and CD 
patients 
regardless of 
disease activity. 
Participants 
and 
investigators 
were not 
blinded. 
Most of the 
Crohn’s 
disease 
patients were 
currently in 
remission or 
mild disease. 
Schäffler, H., Schmidt, M., 
Huth, A., Reiner, J., Glass, Ä. 
and Lamprecht, G. (2018). 
Clinical factors are associated 
with vitamin D levels in IBD 
patients: A retrospective 
Determine if there 
is a correlation 
between vitamin 
d deficiency and 
clinical 
parameters in IBD. 
Retrospective 
study of 
patients with 
IBD. Outpatient 
clinic in 
Rostock, 
Germany 
Patients were 
divided into 2 
groups, one 
with vitamin D 
supplements 
and one 
without. All 
208 IBD patients 
were evaluated. 
123 CD, 85 UC. 
Treatment with 
azathioprine did 
not seem to 
affect vitamin D 
Vitamin D 
deficiency is 
common in 
patients with 
IBD and may 
require close 
Did not test 
sunlight 
exposure in 
these 
patients. 
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analysis. Journal of Digestive 
Diseases, 19(1), pp.24-32. 
 
Grade I 
enrolled 
patients with 
UC/CD from Jan 
2011 to Sept 
2014 and were 
retrospectively 
analyzed.  
had serum vit 
D levels and 
disease activity 
evaluated. 
Severe 
deficiency 
<27.5 nmol/L, 
deficiency 
<50nmol/L, 
insufficiency 
<75nmol/L, 
normal 
>75nmol/L. 
levels or disease 
activity. 
Significantly 
lower vitamin D 
levels were 
found in CD 
patients or if 
more of the 
bowel had been 
resected.  
monitoring for 
deficiency.  
Venkata, K., Arora, S., Xie, F. 
and Malik, T. (2017). Impact 
of vitamin D on the 
hospitalization rate of Crohn's 
disease patients seen at a 
tertiary care center. World 
Journal of Gastroenterology, 
23(14), p.2539. 
 
Grade I 
Examine the 
relationship 
between vitamin 
d and 
hospitalization 
rate in Crohn’s 
disease. 
Retrospective 
cohort study in 
adult patients 
with CD for at 
least one year. 
Serum vitamin 
D levels were 
assessed and 
divided into 
low mean 
vitamin d level 
<30 ng/ml vs 
normal 30-
100ng/ml.  
Generalized 
Poisson 
Regression 
Models were 
used, and 
incidence rate 
ratios were 
used for CD 
that had been 
hospitalized. 
880 CD 
patients were 
CD with a lower 
mean vitamin D 
level were 2x 
more likely to 
be hospitalized 
compared to 
those with a 
normal vitamin 
D level. Higher 
vitamin d levels 
were associated 
with 3% lower 
likely hood of 
admission. 
Normal vitamin 
D levels may be 
beneficial in CD 
clinical course. 
Small number 
of 
hospitalized 
patients were 
looked at. 
Retrospective 
study and 
EMR use. 
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looked at. 196 
had vitamin D 
levels and 
were included. 
Sharifi, Amrollah et al. 
"Vitamin D Status and Its 
Relation to Inflammatory 
Markers In Patients With Mild 
To Moderate Ulcerative 
Colitis". Middle East Journal 
of Digestive Diseases, vol 10, 
no. 2, 2018, pp. 84-89. 
International Society for 
Phytocosmetic Sciences, 
doi:10.15171/mejdd.2018.95. 
Grade I 
Cross-sectional 
study 
Assess vitamin D 
status in Iranian 
patients with UC 
and its correlation 
with ESR, hs-CRP. 
129 Tehran 
inhabitants, 
ages 18-50 with 
mild to 
moderate UC. 
Ultimately 90 
participated. 
Blood samples 
of 25 (OH)D3, 
hsCrp and ESR 
were 
measured. 
Demographic 
data was 
collected was 
collected by 
interviewing 
participants. 
Avg serum vit D 
was 33.1 +/- 8.3 
ng/mL. 
37.3% of men 
and 41% of 
women were 
deficient or 
insufficient. No 
sig correlation 
was found 
between 
vitamin D and 
hs-CSR, ESR. 
Those with mild- 
mod UC that 
had vit D 
insufficient or 
deficient were 
not corollate 
with hs-CRP, 
ESR. More 
studies are 
needed.  
No control 
group. 
Of 129 
eligible 
participants 
only 90 
participated. 
Only patients 
with mild- 
mod UC and 
between the 
ages of 18-50 
were 
included. 
Ulitsky, Alex et al. "Vitamin D 
Deficiency in Patients with 
Inflammatory Bowel Disease". 
Journal of Parenteral and 
Enteral Nutrition, vol 35, no. 
3, 2011, pp. 308-316. Wiley, 
doi:10.1177/0148607110381
267. 
Grade I 
Examine the 
potential 
association of 
vitamin D 
deficiency with 
increased 
inflammatory 
bowel disease and 
the decline in 
quality of life. 
Retrospective, 
observational 
study 
Patients being 
followed in the 
Medical College 
of Wisconsin’s 
IBD Center. 
25(OH)D level 
Demographic 
data, disease 
location and 
medication use 
was obtained. 
IBD 
questionnaire 
to determine 
quality of life. 
504 IBD 
patients, 403 
Crohn’s,  
101 UC. 
49.8% were 
deficient and 
10.9% severely 
deficient. 
Deficiency was 
associated with 
lower quality of 
life score. 
Vitamin D 
deficiency is 
common in 
patients with 
IBD and lower 
quality of life. 
Retrospective 
Del Pinto, Rita et al. 
"Association Between 
Inflammatory Bowel Disease 
and Vitamin D Deficiency". 
Look at the 
association 
between IBD and 
Vitamin D 
Meta-analysis 
and systemic 
review.  
Electronic 
databases 
were examined 
from by 2 
IBD patients 
were 64% 
higher chance 
of being Vitamin 
IBD is associated 
with having an 
increased 
chance of 
Observational 
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Inflammatory Bowel Diseases, 
vol 21, no. 11, 2015, pp. 
2708-2717. Oxford University 
Press (OUP), 
doi:10.1097/mib.0000000000
000546. 
different 
authors for 
presence of 
Vitamin D 
deficiency and 
IBD and a 
control group 
without IBD. 
14 studies 
were 
identified. 
938 control 
and 953 
control. 
D deficient, 
compared to 
control group. 
Latitude did not 
seem to impact 
results. 
Vitamin D 
deficiency. 
Liver Disease 
Ahmed, Furqaan. "Prevalence 
of Vitamin D Deficiency 
Among Non-Cirrhotic 
Pakistani Patients with 
Chronic Viral Hepatitis And 
Non-Alcoholic Fatty Liver 
Disease". Journal of Liver: 
Disease & Transplantation, 
vol 04, no. 02, 2015. OMICS 
Publishing Group, 
doi:10.4172/2325-
9612.1000129. 
Grade I 
Determine 
prevalence of 
vitamin D 
deficiency in 
patients with 
chronic liver 
disease and its 
relationship to 
severity of liver 
dysfunction. 
118 patients 
with chronic 
liver disease at 
the Hepatology 
Clinic at the 
University of 
Tennessee 
Health Science 
Center. 59 
males and 59 
females.  
Vitamin D 
status and 
clinical profile 
was examined. 
Analysis was 
preformed to 
determine if 
age, gender, 
race, BMI, DM 
or severity of 
disease 
planned a role 
in vitamin D 
deficiency. 
Vitamin D 
deficiency was 
observed in 109 
out of 118 
patients. 
92% of chronic 
liver disease 
patients 
experience 
vitamin d 
deficiency. 
PTH was not 
measured 
and could not 
explain the 
interaction 
between PTH 
and vitamin d 
calcium levels 
in liver 
disease. 
Barchetta, Ilaria et al. "Strong 
Association Between Non-
Alcoholic Fatty Liver Disease 
(NAFLD) And Low 25(OH) 
Vitamin D Levels in An Adult 
Test a hypothesis 
that there was an 
association 
between 
262 subjects 
from the 
Diabetes and 
Hepatology 
clinic of 
NAFLD was dx 
by ultrasound. 
Serum vitamin 
D measured. 
Subjects with 
NAFLD were 
found to have 
lower levels of 
Lower serum 
vitamin was 
associated with 
NAFLD 
Ultra sound is 
not the gold 
standard to 
detect liver 
disease 
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Population with Normal 
Serum Liver Enzymes". BMC 
Medicine, vol 9, no. 1, 2011. 
Springer Nature, 
doi:10.1186/1741-7015-9-85. 
Grade II 
hypovitaminosis D 
and the NAFLD. 
Sapienza 
University of 
Rome. 
vitamin D than 
those without. 
although 
practical. 
Cross-
sectional 
design due to 
no 
established 
causality 
nexus. 
Less common 
liver diseases 
causes could 
not be ruled 
out. 
Eliades, M. et al. "Meta-
Analysis: Vitamin D and Non-
Alcoholic Fatty Liver Disease". 
Alimentary Pharmacology & 
Therapeutics, vol 38, no. 3, 
2013, pp. 246-254. Wiley, 
doi:10.1111/apt.12377. 
Grade I 
Study the 
association 
between vitamin 
D levels and 
NAFLD 
Studies were 
compared from 
PubMed and 
EMBASE 
regarding 
vitamin D 
status and 
NFLD 
17 cross 
sectional and 
case-controlled 
studies were 
evaluated 
Deficiency of 
vitamin D were 
1.26 times more 
likely in those 
with NAFLD 
NAFLD have 
decreased 
serum vitamin D 
levels 
determining as 
association. 
Causal role 
could not be 
established 
and would 
require 
further 
studies. 
Yang, et al. "The Value of 
Severe Vitamin D Deficiency 
in Predicting the Mortality 
Risk of Patients with Liver 
Cirrhosis: A Meta-Analysis". 
Clinics and Research in 
Hepatology and 
Gastroenterology, 2019. 
Elsevier BV, doi: 
10.1016/j.clinre.2019.03.001. 
Grade II 
Look at the 
relationship 
between severe 
Vitamin D 
deficiency and 
mortality of liver 
cirrhosis patients. 
Meta- analysis 
of 
observational 
studies. 
8 studies from 
March 2013 to 
Jan 2019 were 
included 
Severe vitamin 
D deficiency 
was associated 
with a higher 
risk of mortality 
in cirrhosis liver 
disease 
patients. 
Vitamin D level 
may be a new 
level to use to 
look at 
prognosis in 
liver cirrhosis 
patients. 
Vitamin D 
supplementatio
n was strongly 
suggested in 
these patients. 
All studies 
were 
conducted in 
Europe. May 
not reflect 
the entire 
world. Larger 
populations 
could be 
looked at. 
Small sample 
size. 
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Wang, Ningjian. "Vitamin D 
and Nonalcoholic Fatty Liver 
Disease: Bi-Directional 
Mendelian Randomization 
Analysis". Ebio medicine, vol 
28, 2018, pp. 187-193., doi: 
10.1016/j.ebiom.2017.12.027
. Accessed 18 July 2019. 
Grade I 
Look at the 
relationship 
between Vitamin 
D and NAFLD 
9182 
participants 
were polled in a 
study in Eastern 
China in 2014 
to 2016.  
Genetic risk 
scores were 
calculated for 
vitamin D 
levels and 
NAFLD. Liver 
steatosis was 
looked at by 
ultrasound. 
Increased 
genetic risk 
scores were 
associated with 
Vitamin D levels 
but not with 
NAFLD.  
No causal 
relationship 
between NAFLD 
and Vitamin D 
status 
Study was 
conducted in 
China, not 
represented 
of the entire 
world. 
Vitamin D 
was only 
measured 
once. 
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Results Review 
The most common areas involving gastrointestinal disease and Vitamin D were divided 
into subgroups to understand further the prevalence of Vitamin D deficiency in that particular 
disease state.  
 
Parenteral Nutrition 
Because the majority of patients requiring parenteral nutrition are not able to meet 
their estimated nutritional needs orally due to obstruction or absorption issues, the absorption 
of Vitamin D and calcium can also be impacted. While sunlight exposure can synthesize Vitamin 
D, dietary intake of Vitamin D sources also plays a role and requires parts of the small bowel, 
liver, and pancreas for Vitamin D absorption. Vitamin D insufficiency in these patients increases 
the risk for metabolic bone disease and can cause other complications such as falls and fractures 
requiring hospitalization (Deluca, 2009). 
In reviewing studies involving prevalence of low Vitamin D status and individuals requiring 
parenteral nutrition, the majority studied were receiving home parenteral nutrition (PN) due to 
their stability on PN versus hospitalized individuals (Bharadawaj, et al., 2012; Thomson, et al., 
2011; Deluca, 2009).  Reasons found for requiring parenteral nutrition including gastrointestinal 
dysmotility, short bowel syndrome, and malabsorption. A high prevalence of Vitamin D 
deficiency and insufficiency was demonstrated in home parenteral nutrition patients (Thomson 
et al., 2011). Lab values such as 25(OH)D, phosphorus, magnesium and ionized calcium were 
analyzed (Thomson et al., 2011). Dietary recall was also examined in multiple studies for Vitamin 
D content and its role in Vitamin D status.  The incidence of less than optimal Vitamin D status 
and bone loss in adults with short bowel syndrome after weaning off total parenteral nutrition 
was also examined (Fan et al, 2016).  
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Supplementation of Vitamin D in home PN patients is common but limited. It was found 
that home parenteral nutrition patients were receiving an IV multivitamin in their parenteral 
nutrition formulation that included 200- 400IU of Vitamin D (Thomson et al., 2011; Bharadawaj 
et al., 2012; Deluca,2009; Napartivaumnuay et al., 2017). Oral supplementation of 50000 IU was 
prescribed for patients identified to have a 25(OH)D level < 20ng/mL identifying deficiency 
(Bharadawaj et al., 2012).  
Outcomes in parenteral nutrition patients demonstrated chronic insufficiency, with only 
small amounts of home parenteral nutrition patients having sufficient levels (Bharadawaj et al., 
2012). It was thought that limited exposure to sunlight due to chronic conditions, as well as 
gastrointestinal disorders impairing Vitamin d absorption, played a role (Thomson et al., 2011). 
Deficiency was common even in PN patients on oral supplementation, and even at higher 
replacement doses it was hard to achieve satisfactory status (Fan et al., 2016).  Patients on 
home PN were also at increased risk of metabolic bone disease as it was found that low vitamin 
D levels impacted low bone mineral density as well (Fan, et al., 2016; Deluca, 2009). 
Recommendations in patients dependent on parenteral nutrition, included routine 
screening for Vitamin D status and vitamin D levels are kept within normal range as able 
(Bharadawaj et al., 2012; Deluca, 2009). Supplementation of Vitamin D by mouth, as well as 
through parenteral nutrition multivitamin were recommended in addition to routine screening. 
(Thomson et al., 2011). Other recommendations included screening for bone mineral density 
routinely and considering alternative methods of supplementation when weaning from 
parenteral nutrition (Fan, et al., 2016). Further research on the use of UV exposure therapy may 
be beneficial as IV Vitamin D is currently not available in the United States (Deluca, 2009). 
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Hepatic Disease 
Patients that experience liver failure or diseases affecting the liver are at risk for Vitamin 
D deficiency, due to the liver’s impaired ability to properly synthesize vitamin D (Nair, 2012).  A 
study involving 118 liver disease patients found that 92.4% of them has some degree of Vitamin 
D deficiency (Nair,2012; Ahmend et al, 2015). The degree of deficiency seemed to be related to 
the severity of liver disease and impairment, but deficiency was also observed in patients 
without liver failure (Nair, 2012). Patients who have undergone a liver transplant and  
Liver transplant patients who experience Vitamin D deficiency could experience an 
accelerated loss of bone due to increased risk (Nair,2012). Side effects of interferon therapy, 
commonly taken in transplant patients, such as achy muscles, could be exacerbated by low 
Vitamin D levels as well (Nair, 2012).  
Vitamin D status and nonalcoholic fatty liver disease (NAFLD) had a strong association. 
Lower serum Vitamin D levels were observed in subjects with NAFLD than those without 
(Barchetta et al., 2011). It was concluded subjects with NAFLD were 1.26 times more likely to 
experience Vitamin D deficiency (Eliades et al., 2013). Severe Vitamin D deficiency was 
associated with a higher risk of mortality in cirrhosis liver disease patients (Yang, 2019). 
Emerging research suggest Vitamin D level may be a new level to look at potential prognosis in 
liver cirrhosis patients (Yang, 2019). 
Awareness of Vitamin D deficiency and liver disease can help encourage monitoring of 
Vitamin D status and initiating supplementation (Nair, 2012). Vitamin D supplementation may 
also be beneficial for patients with liver disease in the progression of disease and treatment 
response (Keane, 2018).  A clinical trial was conducted looking at patients with non-alcoholic 
fatty liver disease. It was noted that the supplementation of Vitamin D helped to reduce fat 
infiltration in the liver (Ifigenia, et al, 2016). Initially, the liver was studied due to the presence of 
 35 
 
Vitamin D receptors within the liver and found that the most severe cases of Vitamin D 
deficiency, was correlated with severe cases of non-alcoholic fatty liver disease (Ifigenia, et al, 
2016). It was concluded that Vitamin D supplementation improved hepatic steatosis after only 
four weeks (Ifigenia, et al, 2016). 
 
Inflammatory Bowel Disease 
Inflammatory bowel disease (IBD) typically refers to Crohn’s disease and ulcerative 
colitis. Vitamin D status can be an issue in those affected by this disease as they can experience 
absorption issues or surgical resections of the intestine. Vitamin D plays a role in maintaining the 
integrity of the gastrointestinal barrier, immune response and a role in surveying the gut 
microbiota, which can play a role in the disease progression and patients’ symptoms (Fletcher et 
al, 2019).  
Studies involving IBD and Vitamin D status looked at several areas to see if a correlation 
was present. Areas explored IBD and inflammatory state of the bowel, the association of 
Vitamin D and erythrocyte sedimentations rate (ESR) as well as high sensitivity C- reactive 
protein measurements in ulcerative colitis patients (Sharifi et al., 2018). No significant 
correlation was found between 25(OH)D levels, high sensitivity C-reactive protein, BMI or the 
duration of disease (Sharifi et al, 2018).  No difference in serum Vitamin D levels was observed 
among both sexes. It was noted 38.9% of patients were insufficient or deficient in Vitamin D. 
The risk of IBD and serum levels of 25(OH)D was also examined in both Crohn’s and ulcerative 
colitis patients. No major role of Vitamin D levels and inflammatory bowel disease was 
demonstrated (Lund-Nielsen et al., 2018). A positive correlation was also seen between serum 
Vitamin D levels and the time between initial diagnosis and being on appropriate interventions 
(Zammit, et al., 2018).  Vitamin D status and quality of life in these patients were also 
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associated. Obtaining Vitamin D levels upon diagnosis is helpful in it may be used to indicate the 
severity of the disease (Zammit et al., 2018). Those that had inflammatory bowel disease were 
compared to healthy people of the same age and found to have significantly reduced levels 
compared to healthy subjects. Those that were female and had Crohn’s disease were more likely 
to be Vitamin D deficient (Han et al., 2017). 
Studies compared if Crohn’s had the same prevalence for Vitamin D insufficiency as 
ulcerative colitis. It was found that 49% of subjects who had serum Vitamin D levels < 50nmoll/L 
53% had Crohn’s disease and 44% had ulcerative colitis. There was an association between 
Crohn’s disease relapses within the last year and Vitamin D deficiency. Vitamin D deficiency was 
common in all inflammatory bowel disease patients but higher in those with Crohn’s (Frigstad et 
al., 2016). Another cross-sectional study compared Vitamin D levels and inflammatory bowel 
disease patients and irritable bowel disease patients. Fifty-eight Crohn disease patients and 25 
ulcerative colitis patients had a Vitamin D level less than 50 nmol/L, indicating insufficiency or 
deficiency. Patients with Crohn’s disease had significantly lower levels of Vitamin D than those 
with irritable bowel disease; this relationship was not found in those with ulcerative colitis 
(Caviezel et al., 2017). While Vitamin D deficiency is common in inflammatory bowel disease 
patients, it was more common specifically in Crohn’s disease patients than ulcerative colitis 
patients (Caviezel et al., 2017). IBD patients were 64% higher chance of being Vitamin D 
deficient, compared to a control group (Del Pinto, 2015). Findings suggested latitude did not 
seem to impact results (Del Pinto, 2015). 
Supplementation was also trialed in patients with inflammatory bowel disease (IBD). A 
prospective, pilot randomized controlled trial to evaluate Vitamin D supplementation in patients 
with inflammatory bowel disease that were deficient or insufficient in Vitamin D was conducted. 
Three groups were formed, one received Vitamin D supplement, one received elemental 
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calcium, and one group received nothing. The group that received the Vitamin D 
supplementation had higher levels of 25OHD than the other two groups.  It was determined that 
Vitamin D supplementation is necessary in this population (Tan et al., 2018). 
Vitamin D status may also play a role in hospitalizations in patients with IBD. A 
retrospective study to examine the relationship between Vitamin D and hospitalization rate in 
patients with Crohn’s disease.  It was found that patients with Crohn’s disease and low Vitamin 
D were two times more likely to be hospitalized than those with normal Vitamin D levels. Higher 
Vitamin D levels were associated with 3% lower likelihood of hospital readmission. It was found 
that adequate Vitamin D status may be beneficial in Crohn’s patients’ clinical course (Venkata et 
al., 2017). 
 
Intestinal Failure 
A review examined the loading dose Vitamin D deficient patients with intestinal failure. 
It was found that Vitamin D3 cholecalciferol was an effective treatment in patients with 
intestinal failure. It was effective between 20000-40000IU one time per week or 4,000-6,000 
IU/day on the other 6 days of the week (Grenade et al., 2016). Those with intestinal failure may 
also be relying on parenteral nutrition or a combination of parenteral and oral nutrition. The 
relationship with intestinal failure patients, Vitamin D status and bone density in lumbar and 
femoral regions were examined to determine if they were at higher risk of osteoporosis.  It was 
found there was not a correlation between Vitamin D levels and bone density in these regions 
(Ellegard et al., 2013).  Subjects that were only taking a multivitamin that contained Vitamin D 
had lower Vitamin D levels compared to those on Vitamin D and calcium supplementation. It 
was thought that inadequate sunlight exposure may plan a stronger role in these patients, 
rather than the inability of the intestine to absorb Vitamin D (Margulies et al., 2015). 
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Treatment recommendations 
Different Vitamin D treatment regimens were evaluated and their response to serum 
vitamin D levels in a retrospective study. Subjects were given doses of cholecalciferol ranging 
from 600IU to 1100IU and demonstrated similar changes in serum Vitamin D levels of 8-9.1 
mg/mL. A larger increase in serum Vitamin D levels of 12.7ng/mL was seen with a dose of 
2700IU. A mean dose of ergocalciferol, 11000IU demonstrated an increase of 19.9ng/mL in 
serum Vitamin D levels. Supplementing with lower Vitamin D doses demonstrated a similar 
effect on serum Vitamin D change. Higher doses of supplements can produce higher levels of 
Vitamin D, but the relationship was not linear (Atterrado et al., 2015). 
 
Limitations: 
While this is an important subject, clinicians can be biased on personal practices. As far 
as research limitations, many studies regarding this subject included pediatrics, especially in 
parenteral nutrition patients and therefore were excluded. Areas such as inflammatory bowel 
disease had been explored in depth more recently, while intestinal failure and hepatic disease 
did not have as much literature. 
 
Conclusion: 
Overall, while there were limited studies on adults on parenteral nutrition and Vitamin 
D status, it was found only small amounts of individuals on parenteral nutrition had satisfactory 
Vitamin D status. These individuals also had limited absorption of Vitamin D orally due to bowel 
malabsorption but if able to take medications orally, it is recommended to trial oral Vitamin D 
replacement. Limited Vitamin D is provided within the multivitamin within the parenteral 
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nutrition formulation, only approximately 400IU. Close monitoring and replacement as indicated 
is recommended in parenteral nutrition dependent individuals. 
Very limited research was found regarding intestinal failure and Vitamin D status. 
Individuals that were only receiving Vitamin D supplement provided in parenteral nutrition 
multivitamin were at higher risk of insufficiency than those on oral replacement Vitamin D as 
well. Hepatic diseases were also limited in research with Vitamin D status. Findings of these 
limited studies suggested a relationship with 92% of chronic liver disease patients experiencing 
Vitamin D deficiency and lower serum vitamin D levels in those with nonalcoholic fatty liver 
disease. 
Inflammatory bowel disease and Vitamin D status had the most studies that were 
conducted recently. This may be because of new research connecting Vitamin D and the gastro-
intestinal barrier integrity and immune response. The relationship between inflammatory bowel 
disease and Vitamin D deficiency is still not fully understood and it’s unclear if the deficiency 
came before the disease or vice versa. Vitamin D status and IBD individuals did not seem to vary 
depending on sex, age BMI, or disease duration. Vitamin D deficiency was common in IBD 
individuals, more common in Crohn’s individuals than ulcerative colitis. There may be an 
association with disease activity, relapse and inflammatory activity. It was found Crohn’s 
patients were less likely to get sun exposure than UC patients and they were also more likely to 
be deficient than UC patients. Lower Vitamin D levels may indicate severe IBD, quality of life and 
Vitamin D status were associated, and smoking was associated with lower vitamin D levels. 
Supplementation was recommended regardless of disease activity as well as routine screening. 
Monitoring of all micronutrients in IBD patients was recommended as well due to impaired gut 
function. Further research is needed to determine if supplementing Vitamin D improves 
inflammation and severity of disease in IBD patients. 
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  Vitamin D status should be obtained on the following types of patients Crohn’s disease, 
ulcerative colitis disease, hepatic disease, short gut syndrome, and other bowel resection 
surgeries as well as those on parenteral nutrition with malabsorption disorders, to determine if 
deficiency or insufficiency is present.  
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